Breast Cancer Res Treat. 2026 Nov 14;220(1):35. doi: 10.1007/s10549-026-08128-8.
ABSTRACT
BACKGROUND: Long-term female breast cancer survivors are at increased risk of cardiovascular disease (CVD), yet the biological mechanisms underlying this vulnerability remain poorly defined. Identifying non-invasive biomarkers capable of capturing early cardiovascular alterations in this population represents a relevant unmet clinical need.
METHODS: Twenty-four long-term female breast cancer survivors were enrolled and stratified according to cardiovascular disease history (CVD+, n = 12; CVD-, n = 12) and matched by age. A selected panel of 13 circulating microRNAs (miRNAs), together with adipokines and inflammatory cytokines, was analyzed in plasma samples.
RESULTS: No significant differences were observed between groups in circulating adipokines or inflammatory markers. In contrast, miR-125b-5p and miR-210-3p were significantly downregulated in survivors with CVD compared with matched CVD- subjects. Correlation analyses revealed distinct, condition-specific association patterns between miRNA expression and cardiometabolic parameters.
CONCLUSIONS: The reduced circulating expression of miR-125b-5p and miR-210-3p in long-term breast cancer survivors with cardiovascular disease suggests a potential involvement of these miRNAs in vascular homeostasis and hypoxia-related pathways. These findings support circulating miRNAs as promising exploratory biomarkers for cardiovascular risk stratification in cancer survivorship, warranting validation in larger prospective studies.
PMID:43033308 | DOI:10.1007/s10549-026-08128-8

